US Patent Issued to INVOX PHARMA on May 13 for "Fc binding fragments comprising an OX40 antigen-binding site" (British Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,283, issued on May 13, was assigned to INVOX PHARMA Ltd. (London).

"Fc binding fragments comprising an OX40 antigen-binding site" was invented by Mihriban Tuna (London), Miguel Gaspar (Cambridge, Great Britain), Sandra Uhlenbroich (Cambridge, Great Britain), Katy Everett (Cambridge, Great Britain) and Delphine Buffet (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The application relates to specific binding members that bind OX40. The specific binding members comprise an OX40 antigen-binding site located in a constant domain of the specific binding member and find application in the treatment of cancer and infectious disease...